Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for the info, Fox!
Daniel
Mike,
My apologies. We've seen so many false claims over the years, intended to cast DNAG in a negative light, that many of us (myself definitely included) have become quite skeptical.
Thanks for posting.
Daniel
Detonate,
You're welcome. I'm talking with the company, and I'll release information as I can.
Daniel
Richard Gabriel announced his resignation last week. An 8K filing should be coming soon, to reflect this. Another thing I can say, which has been no secret, is that DNAPrint Genomics needs funding.
There's something else I'm planning to write up and post soon, as well.
Daniel Gannon
Steinburger,
I completely understand. As you and others are probably aware, due to my posting here, I emailed the company (at multiple DNAPrint email addresses,) offering to help. Things are getting to the point where I have to be careful what I say. I wish I could be more forthcoming. I'll see what, if, and when I can post about particular things.
Daniel
The most meaningful measure of an R&D company's success, is the value of the intellectual property that is produced, compared to the funds used. I'm not the only one who considers DNAPrint Genomics a resounding success, in this. The value is becoming increasingly obvious, especially now that Personalized Medicine's day appears to have arrived, even ahead of many projections.
That R&D companies use money, often get stuck with toxic financing, fall victim to blatant stock manipulation, and are often plagued by vultures, should come as no surprise to anyone familiar with such matters.
The harder and more frequently a "dead horse" is flogged, the more it becomes apparent, that the vultures covet it intensely, and that it's no "dead horse," at all, but quite valuable, indeed.
Still not selling a single share,
Daniel
Maybe you haven't paid attention?
Wikipedia entry on Personalized Medicine:
http://en.wikipedia.org/wiki/Personalized_medicine
Another acquisition in the Personalized Medicine space:
Avacta acquires TheraGenetics
Pharmaceutical Business Review - 8 hours ago (according to Google)
Published:03-February-2009
http://drugdiscovery.pharmaceutical-business-review.com/news/avacta_acquires_theragenetics_030209
Avacta, a UK-based biophysics company, has acquired TheraGenetics, a personalized medicine diagnostics company that is developing and commercializing a portfolio of pharmacogenetic diagnostic tests to guide and improve the treatment of central nervous system disorders.
Theragenetics, a personalised medicine diagnostics company which develops tests to improve the treatment of patients with central nervous system (“CNS”) disorders such as schizophrenia and depression.
Under the terms of the agreement, TheraGenetics will be acquired for a combination of cash and stock. Additionally, under the agreement, the US operations will remain in Cambridge, Massachusetts.
Richard Kivel, CEO of TheraGenetics, said: "We are pleased to announce the successful acquisition of TheraGenetics by Avacta. We have made tremendous progress in our efforts to link genes to specific CNS disorders and advance the development of our diagnostic tests to determine patient response to treatment as well as drug side effects.
"The acquisition by Avacta strongly positions the company from both a resource and technology standpoint, as we seek to expedite our development programs and build a foundation for future diagnostic tests for the most common central nervous system conditions."
This Acquisition follows the announcement by the Company on 9 January 2009 of the proposed acquisition of Curidium Medica plc (“Curidium”) which, similarly, operates in the field of CNS personalised medicine whilst employing complimentary, non-conflictive science and technology.
DNAPrint Genomics very clearly is a part of the Personalized Medicine space, as even the most casual observer can see. Don't be confused by the various terminology... "personalized medicine," "pharmacogenomics," "theranostics," etc. This is about personalized medicine, by whatever name it's called. It's not uncommon for an emerging field or industry to have multiple descriptive names, in its formative stages. "Personalized Medicine" appears to be the leading term at this moment, largely because the Obama administration refers to it as that.
http://www.dnaprint.com/welcome/corporate/
Relevant excerpt:
Pharmacogenomics Market - The testing of individuals to predict their genetic predisposition to drug response is known as pharmacogenomics. Pharmacogenomics enables physicians to tailor drug therapies (formulation and dosage) for individuals based on their genetic composition, increasing rates of therapeutic success and decreasing rates of adverse side effects. Drug discovery companies are beginning to use pharmacogenomics technologies to develop drugs that are suitable for subpopulations based upon their genetic composition. We at DNAPrint® believe that as doctors and health care providers have been reporting for thousands of years; that different peoples from different countries have variable responses to medications is reason enough for us to explore this realm of medicine. We hope to be able to help predict whether a woman taking a chemotherapy agent for a cancer will respond favorably to a drug. We also will apply our technology to our own therapeutics, such as PT-401 a ‘super EPO’. This will help improve the efficacy of the drug therapy going into clinical evaluation as well as helping to improve and maintain patient response efficacy after the drug is approved. Pharmaceutical and pharmaceutical diagnostics are important cornerstones for our future value to our shareholders. We believe individualized medicine, while still some years away, will be here to stay, especially now that the U.S. FDA has written about pharmacogenomics. view PDF
http://www.dnaprint.com/welcome/pdf/2003d-0497-gdl0002.pdf
Totally unsubstantiated, "frogdreaming."
That's nice.
As for me, I'm proud to say, I've still never sold a single DNAG share. I started buying in 2007 at .007, and I've averaged down aggressively, to the point that I now own 231,217,798 shares (17.8575% of the total outstanding shares, according to the registrar's figure on January 28.)
Daniel
"frogdreaming,"
Substantiate all of that, or I believe none of it. Evidence. Links, verifiable quotes, and such.
Also, it is not reasonable, in my opinion, to claim that DNAPrint Genomics' intellectual properties are "worthless," especially now that Personalized Medicine is attracting so much serious attention.
This link that Sam posted, to a recent publication, is relevant:
Race and ancestry in biomedical research: exploring the challenges
January 21, 2009
http://www.genomemedicine.com/content/pdf/gm8.pdf
Try this Google News search, on "personalized medicine." (Sorted by date, only articles from the last month.)
http://news.google.com/news?hl=en&tab=wn&ned=&q=%22personalized+medicine%22&ie=UTF-8&scoring=n
"Results 1 - 10 of about 223 for personalized-medicine."
Daniel
Try this search:
Obama "personalized medicine" bill
http://www.google.com/search?hl=en&q=obama+%22personalized+medicine%22+bill&aq=f&oq=
Also, you can go back and see the articles, with attributions and quotes, that have been posted here. "Fuzzy stuff"... I suppose everything government does might be called "fuzzy," but a lot of "fuzzy" money flows, at the direction of "fuzzy" government.
Daniel
Agreed.
"frogdreaming,"
Another alleged conspiracy, huh? ("The idea back then was to disguise a RS inside the spin-off.")
I don't see anything nefarious in anything the company has done. I see a company that's been behaving ethically, and persistently trying to succeed.
It's very easy to allege things... anything at all. It's quite another thing to substantiate an allegation with evidence and logic (spin that doesn't hold water, doesn't count.) It's very telling when a person making so many allegations, never retracts any of them, no matter how soundly the allegations are disproven.
Why does a small, startup biotech R&D company become publicly traded, in the first place? The answer is obvious: To raise funding. Nothing nefarious in that. If you want to play the game, you should understand it. If/when there's dilution in a stock, an investor can choose to average down, or choose to back out -- two rational decisions, depending on the circumstances. It's completely voluntary, and educated investors are not surprised by the ordinary workings of publicly traded, microcap R&D companies. At least, DNAPrint Genomics has produced some very noteworthy intellectual property, and products, already, with what I (and others) consider a very economical burn rate on their funds.
Unfortunately, there has been entirely too much manipulation, often combined with manipulative propaganda, not only against DNAG, but against many other stocks. The manipulation has been extremely blatant, and I still consider, it has created an extremely undervalued stock (which is why I've bought so many shares, of course.)
I suggest taking some courses on investment. That might clear things up for you, a bit.
Daniel
LOL.
I meant, "Porgie Tirebiter," not "Frogdreaming." But the rest of the message, was as I intend.
Daniel
"frogdreaming,"
So, when DNA Ancestors says it is currently running DNAPrint Genomics' AncestryByDNA tests, in-house, in their lab in Australia, that means to you, "it's looking pretty clear this company no longer transacts anywhere"? I wonder what a company has to do, to satisfy your personal definition of "transacting business." Please don't misconstrue the whole situation, of the lab instrument being down. Reportedly, DNAPrint Genomics thought that instrument would be back online already, but it failed the tray run in mid-January, according to one of the distributors I called. Sarah indicated to me, that they are anticipating the instrument will be up and running relatively soon (she mentioned, 3 weeks, but I know how these things go, it could be sooner, or it could be later... until a tray run passes.) Sure, there is an issue, there. But what you insinuate is way beyond what is reasonable and substantiated.
Daniel
Fox,
That looks like good news.
> (2) The following activities, among others, do not constitute transacting business within the meaning of subsection (1):
[...]
> (i) Transacting business in interstate commerce.
It appears their active Status in Utah _is_ sufficient to permit them to engage in interstate commerce, and all the other exceptions you just quoted. Perhaps DNAPrint Genomics discovered they don't need an active corporation in Florida, that their active status in Utah was sufficient, and letting the Florida corporate registrations (there were three in Florida) lapse, may have been part of their prudent cost-cutting measures, during this financing pinch. Makes sense to me, but of course, this is conjecture, as they haven't told me what their rationale was. This is just my best guess.
Anyway, to reiterate, active status in Utah does appear to be sufficient, to engage in interstate commerce, etc. That's good news, and contradicts many of the doom-and-gloom statements that have been posted here so frequently.
Daniel
Hello Goldenstone77,
Responding to what you said -- "corporations domiciled in one state, can do business in all the other states.
The right to engage in interstate commerce it has often been declared is a federal right, and is, therefore, independent of state control."
If that's so, then a corporation in another state (Utah) can still do business in all other states (including Florida,) without "the certificate of authority to transact business in Florida," which would be a positive in this case. That requirement may just apply to corporations from other nations. I should note, I'm not an expert in this area. Even if that's not so, it shouldn't be difficult for the corporation to become active again in Florida, (as you said, "they basically have to file a report and give them a few dollars,") which isn't, as they say, a "showstopper." At any rate, the intellectual property remains the property of the company, and in my opinion, that alone has value that is currently much greater than what the company owes.
Daniel
"frogdreaming,"
Unsubstantiated.
> Recently the landlord contacted the major shareholder
I did not believe for one second, that the scaremonger who called me was DNAPrint Genomics' "landlord." I do have a suspicion of who it may have been. <ahem>
Daniel
Excellent, Sam, thanks! I note it's dated very recently -- January 21, 2009.
For the newcomers, here is a little background info. to go along with that publication:
DNAPrint Genomics is a pioneer in the AIMs (Ancestry Informative Markers) space.
Informative Google search on this:
aims dnaprint
http://www.google.com/search?hl=en&q=aims+dnaprint&aq=f&oq=
Excerpts from text that pops up immediately, with this search:
"DNAPrint® was the first to validate human AIMs for use in high-throughput screening panels and to reduce their use to genome-screening applications"
"race/history/evolution notes: DNAprint methodologyFeb 29, 2008 ... The supplementary pdf contains a list of the 176 "AIMs" and their allele frequencies for DNAprint's reference poulations, as well as the map..."
"DNAPrint launches 'ethnicity' test. Sep 3, 2004 ... The AIMs were identified from a screen of approximately 12000 candidate AIMs ... Tony Frudakis, Head of Research at DNAPrint Genomics told ..."
"DNAPrint Genomics Receives Notice of Allowance for Patent for ...DNAPrint is also the only company currently using Ancestry Informative Markers (AIMs) and has patents pending in this area as well. ..."
"Race: The Reality of Human Differences - Google Books Resultby Vincent Sarich, Frank Miele - 2005 - Social Science - 304 pages
DNAPrint Genomics has reduced the number of AIMs required to seventy-three and extended the methodology to determine the percentage of racial background in ..."
Alternate search on this topic:
dnaprint "informative markers"
http://www.google.com/search?hl=en&safe=off&q=dnaprint+%22informative+markers%22
"DNAPrint Genomics DNAPrint® 's Core Technology Our proprietary mapping strategy, maps of Ancestry Informative Markers (AIMs), and proprietary, patent-pending methods and ..."
http://www.dnaprint.com/welcome/science/
Daniel
A very revealing Google search:
Obama "personalized medicine"
http://www.google.com/search?hl=en&q=Obama+%22personalized+medicine%22&aq=f&oq=
DNAPrint Genomics owns valuable intellectual property in the Personalized Medicine space.
Patent applications listed, with "frudakis tony" as the applicant or inventor (47 entries) :
http://v3.espacenet.com/searchResults;jsessionid=E8D0863F29E4235E73A8A9CB8DCBFE65.espacenet_levelx_prod_7?locale=en_EP&ST=quick&IA=frudakis+tony&compact=false&DB=EPODOC
Patent applications listed, with "dnaprint genomics" as the applicant or inventor (14 entries) :
http://v3.espacenet.com/searchResults?locale=en_EP&ST=quick&IA=dnaprint+genomics&compact=false&DB=EPODOC
Wikipedia's entry on Personalized Medicine:
http://en.wikipedia.org/wiki/Personalized_medicine
I hope everyone is having a pleasant weekend.
Daniel
"Porgie Tirebiter,"
This statement you made is incorrect, and appears to be based on an outdated outstanding share count: "With today's share price, total market cap is still about one thirteenth of what we know this company owes to creditors."
I have yet to see an online service, that updates outstanding share count correctly. The generally accepted procedure is to call the registrar, for current share count, and not trust what the online services display, for that figure.
When I last called the registrar, on 1/28/2008, DNAG's outstanding share count was:
1,294,790,465 (unchanged since at least 11/17/2008)
Authorized share count remained unchanged, also:
1,500,000,000
Using current share count, at Friday's closing price of .0013, market cap is a little over $1.68M. Multiply that by 13 (to check your scenario) and the result is around $22M. I have seen no estimate that claims their debt is so high; the estimates I've seen have all been much closer to $10M, so instead of 1/13th, the actual number is probably much closer to 1/6th. As we know, DNAG market cap has increased considerably, in recent months. I would not be surprised to see DNAG's market cap surge past $10M, or even $100M, relatively quickly.
Registrar contact information:
Standard Registrar & Transfer
12528 S 1840 E, Draper, UT 84020-9100, United States
Phone: (801) 571-8844
As it becomes obvious to more investors, that DNAPrint Genomics and all of its assets (including intellectual property) is actually worth, with funding, far more than than what it owes to creditors, it makes sense that investors would be attracted, and securing new funding for DNAG becomes something that is much more likely. As I consider DNAG to be worth far more than $10M, I think that, for DNAG to not obtain funding, would represent a major missed investment opportunity. I also think that, if/when DNAG secures new funding (or income becomes sufficient to negate the need for additional funding,) share price would appreciate very dramatically.
Aside from the numbers I stated above, these statements are my opinions only, of course, but I think they are reasonable.
Daniel
Fox,
Thanks for the report!
I just sent an email to the following addresses associated with DNAPrint Genomics:
dnap@dnaprint.com, RGabriel@dnaprint.com, info@dnaprint.com, pharmacogenomics_info@dnaprint.com, webmaster@dnaprint.com, admin@dnaprint.com, forensics_info@dnaprint.com, genotyping_info@dnaprint.com
Excerpts from my email:
[-begin quotes-]
To whom it may concern at DNAPrint Genomics,
I apologize for sending this to so many of DNAG's email addresses, but I think these are urgent issues, I want to help, and we (other investors and I) are having trouble getting ahold of anyone at DNAPrint Genomics, recently.
FYI, a new investor (there appear to be a number of new DNAG investors, and new people interested in DNAG,) posted the following today:
Link to message:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=35239985
[...]
Please note, I am still interested in helping with the sign outside (hopefully getting it up off the ground, and maybe a new sign made.) I'm also interested if I and/or other investors can do anything, to get the sequencing machine in the lab back up and running. (I left voicemail for DNAG about this, yesterday.)
Also, as I previously mentioned, I am interested in a private placement [...] I hope that, with the recently increased interest from investors, there may be enough interest, from enough investors with enough money, to help DNAPrint pull through this financing pinch, hopefully without falling victim to a hostile takeover, or forced to accept more financing on less than desireable terms.
Please email me, or call me on my cell phone. [...]
Sincerely, and best wishes,
Daniel Gannon (shareholder, and long-time defender of DNAG on certain message boards)
[-end quotes-]
I hope someone gets back to me soon. I last spoke to Sarah on the phone just a little over a week ago. With everything that DNAPrint Genomics has going for it, including valuable intellectual property in the Personalized Medicine space (a rapidly emerging field the Obama administration strongly supports,) their talent and expertise, and their track record of persistence and integrity, I think it's in the interest of investors like myself, to help DNAPrint Genomics get through the current financing pinch, so it can grow into its potential, which I consider to be massive.
P.S., this may represent another ray of hope:
"The Obama administration will soon announce a new economic strategy that would lower mortgage costs and extend credit to small businesses..."
Quoted from:
By Amy Hoak, MarketWatch
Last update: 11:53 a.m. EST Jan. 31, 2009
New Obama strategy could lower mortgage costs
http://www.marketwatch.com/news/story/New-Obama-strategy-could-lower/story.aspx?guid=%7B10B27760-59F9-49F8-894A-10D7773B466B%7D
(If clicking the above link, add the %7D to the end in the address bar, because that's supposed to be part of the link.)
Recessions, especially credit-centered ones like this one, often hit small businesses very hard. DNAPrint Genomics is no exception. I strongly believe that DNAPrint Genomics deserves to survive, and thrive. They've made it this far, and made some very noteworthy (and widely noted) progress in various areas -- it wouldn't make any sense to give up now. All of this is my opinion, of course, but I know I'm not alone in this conviction.
Daniel
Here's another update on my inquiries:
I've called some of these companies, and sent emails to the rest, asking these two questions:
- Does DNAPrint's lab do the AncestryByDNA testing for your company, does your company do its own testing, or is the testing done somewhere else?
- After we send our samples in, approximately how long do you think it would be, before we get our printed results back?
There were mailer daemon failures for two of the email addresses, so I'll try calling them on Monday.
Here are a couple more results, I've received:
- Caribbean Genetics uses DNAPrint Genomics' lab, to process the tests. Said they have "suspended taking samples until they are back online," and will email me as soon as the lab instrument is back online.
- EarthOrigins™ DNA Ancestry Testing replied to my email
"We no longer offer this type of testing. We have replaced it with our
proprietary test called Ancestral Origins:
http://www.gtldna.com/ancestral-origins-dna-ancestry.html "
If they aren't using DNAPrint Genomics' Ancestrally Informative Markers, I wonder how informative that test might (or might not) be. If they are using the markers, I hope they are paying licensing fees to DNAPrint Genomics, avoiding infringement.
I'll keep you all posted. I'm hoping DNA Ancestors isn't the only company doing their own AncestryByDNA test processing, aside from DNAPrint Genomics (which is having lab equipment issues, as previously stated.)
I hope everyone has a great weekend.
Daniel
Hi e-ore,
I don't think it has anything to do with the stem cell stocks, really. The Obama administration strongly supports personalized medicine, which is a different area, and DNAG is in the personalized medicine space.
Google search: Obama "personalized medicine"
http://www.google.com/search?sa=N&tab=nw&q=Obama%20%22personalized%20medicine%22
There have been some informative news articles posted here, about this.
Have a great weekend, and good luck!
Daniel
I'm getting more calls, asking about DNAPrint Genomics, again today. (They get my phone number from my SEC filings.)
Daniel
You're very welcome, sd3445 and Detonate.
Detonate, I'm not sure what the issue is, with that machine in DNAG HQ's lab. I just left a voicemail for DNAPrint, asking for any update they may have, about the machine's estimated availability date. (Since my wife I both want to take the AncestryByDNA 2.5 test, and I'd also like to have any info. I can, as an investor.)
I'll continue to post with updates as I receive them, and as my schedule allows.
Daniel
Good news... early update:
I've found one company, so far, that says they _are_ running AncestryByDNA on their own equipment, in their own lab. They told me their lab is in Australia.
DNA Ancestors
Based in Australia, serving multiple countries (including Australia, Canada, Ireland, U.S.A., and U.K.)
"...has experienced tremendous growth and expanded in to over 35 countries across the globe. Specializing in DNA testing services & focused on the development of innovative genetic testing services & associated products. Our laboratory procedures have achieved the highest standards with the prestigious award of the ISO 17025 accreditation."
http://www.dnaancestors.com/
I called their USA phone number: 888-900-9040
DNA Ancestors told me the longest it has taken for people to receive their printed results, is 60 to 90 days. Usually sooner.
Note: Another company I spoke with today is Genelex, in Seattle, Washington. They said they don't run their own tests, DNAPrint Genomics does, and said that the machine that's been down in the DNAPrint lab, has been down for "a solid 3 months." They said DNAPrint thought it would be up and running in mid-January, but when they did a test run in mid-January, the tray run failed, so it will take more time to get the machine back up and running. (Note: We now have confirmation that they didn't hock that machine, contrary to what one unsubstantiated claim from an anonymous detractor, but that the machine is simply down, still present in the lab.)
I'm still contacting many other AncestryByDNA distributors (I've called a few on the list, so far, with these questions.) I'll report back again, relatively soon.
Daniel
Actually, we're in a significant uptrend. The way I look at it, we're well off the low of .0002. Just earlier this week, we were at .0007 - .0008, and we're currently at .0012. Stocks generally don't move in straight lines; I fully expect a lot of volatility.
I'm holding long term because I see a lot of value in this stock, but momentum players, and people without much patience or conviction with this stock, would tend to sell early. There's always a shakeout in situations where a stock crashed and burned, then makes a recovery -- most who bought near the bottom sell long before the stock achieves its later highs (and, I'm sure, kick themselves for doing it, after the fact.) My strategy takes these factors into account; I'm prepared to hold most of my shares, all the way up, for years and years.
Daniel
Hello, e-ore,
You're very welcome. mbmun, You're quite welcome, as well.
I'm happy to share the info I obtain, pertaining to DNAG.
Best of luck to all,
Daniel
I plan to report, another day soon, the results of my inquiries (seeking to determine which of these companies may be currently running AncestryByDNA tests on their own equipment, per the Beckman Coulter - DNAPrint Genomics sales and marketing agreement.)
Daniel
Updated List of AncestryByDNA Distributors
(According to the distributors' websites)
Updated January 29, 2009
Notes: I currently count 31 distributors with no issues detected, and 1 distributor with issue detected (included at the end of the list.)
All My Roots ["African-American DNA Tests"]
U.S.A. [Chicago, Illinois]
http://www.allmyroots.com/order.html
Andergene Labs
U.S.A. [Oceanside, California]
http://www.andergene.com/famhist.html
Caribbean Genetics
Jamaica, with collection sites in Tobago, Antigua, St.Lucia, Belize, Trinidad, Dominica and Barbados
http://www.caribbeangenetics.com/ancestry%20intro.html
Determigene
U.S.A. [collection sites throughout the U.S.A.]
http://www.determigene.com/detail_ancestry.asp
DNA Ancestors
Multiple locations, including Australia, Canada, Ireland, U.S.A., and U.K.
"...has experienced tremendous growth and expanded in to over 35 countries across the globe. Specializing in DNA testing services & focused on the development of innovative genetic testing services & associated products. Our laboratory procedures have achieved the highest standards with the prestigious award of the ISO 17025 accreditation."
http://www.dnaancestors.com/
DNA Ancestry
U.A.E. [Dubai]
http://www.dnaancestry.ae/
Alternate link:
http://www.easternbiotech.com/dnaancestry/Euro_DNA_TM.php
DNA Bioscience - Ethnicity Testing
U.K. [London]
http://www.dna-bioscience.co.uk/service_ethnicity.shtml
DNA Diagnostics
U.K. [Liverpool]
http://www.dnadiagnostics.co.uk/dna_paternity_testing.php?product_name=Ancestry%20by%20DNA
DNA Dimensions
U.S.A. [Metro-Detroit, Michigan]
http://www.detroitdna.com/euro.php?button=4
DNA Direct
U.S.A. [San Francisco, California]
http://www.dnadirect.com/patients/tests/genealogy_testing/what_are_the_tests.jsp
DNA Paternity Justice
U.S.A. [Virginia, USA. "...we supply Ancestry testing in any state." (from email response)]
http://www.dnapaternityjustice.com/ancestrytesting.html
DNA Profiles of America
U.S.A. [Texas]
http://www.dnapoa.com/Ancestry.html
DNA Reference Laboratory
U.S.A. [San Antonio, Texas]
http://www.dnareferencelab.com/ancestry.html
DNA Roots
U.S.A. [Cincinnati, Ohio]
http://www.dna-roots.com/index.html
DNA Test Express
U.S.A. [Houston, Texas]
http://www.ddstest.com/dnatestx/ancestry.html
DNA Testing Solutions
U.S.A. [Collection sites in Florida and Georgia, and "We also serve international clients in over 168 countries."]
http://www.dnatestingsolutions.com/html/ancestry.html
DNA Testing Systems (formerly DNA Consulting)
U.S.A. [Scottsdale, Arizona]
http://dnaconsultants.com/Detailed/437.html
DNA Worldwide
U.K. [Frome]
http://www.dna-worldwide.com/ancestry-testing/combined-ancestry/
EarthOrigins™ DNA Ancestry Testing
U.S.A. [Las Cruces, New Mexico]
https://www.gtldna.net/earth_origins_dna_ancestry.html
easyDNA
New Zealand [Auckland]
http://www.easydna.co.nz/content/index.php?section_id=20
Gene Tree
U.S.A. [Maria Stein, Ohio]
http://www.testsymptomsathome.com/gti77.asp
Genelex
U.S.A. [Seattle, Washington]
http://www.healthanddna.com/ancestry/dna-testing.html
Genetest Corporation
Canada, U.S.A., and U.K. [info per phone call to company, December 9, 2008, 12:55 PM, PST.]
"Our affiliate collection site database consists of thousands of global sites."
http://cytogenetics.genetestlabs.com/services/cytogen_ethnic_ancestry_dna.htm
Genetic Identity
U.S.A. [Eugene, Oregon]
http://ancestrytest.com/Ancestry_Testing/ancestry_testing.html
HomeDNA Home Ancestry Testing
U.S.A. [Keller, Texas]
https://www.homedna.com/ancestry_tests.html
homeDNAdirect
Multiple locations, including Australia, Canada, E.U., France, Ireland, Italy, New Zealand, U.K., and U.S.A.
http://www.homednadirect.com/content/index.php?section_id=20
IDENTIGENE
U.S.A. [Salt Lake City, Utah]
http://www.dnatesting.com/resources/ancestry-test-results.php
International Biosciences
Canada [Edmonton, Alberta]
http://www.ibdna.com/regions/CA/EN/?page=ancestry
Nimble Diagnostics
U.K.
http://www.nimblediagnostics.co.uk/ancordertest_uk.html
Paternity Experts LLC
U.S.A. [Eugene, Oregon, and Las Vegas, Nevada]
http://paternityexpert.com/ancestry_testing.html
RDNAP (Royal DNA Pharmacy)
U.S.A. [Brooklyn, New York]
http://www.royaldnapharmacy.com/Ancestry-DNA-Testing.html
Issue detected with the following distributor listing:
Medical Genomics
U.K., "and Europe" [London address]
http://www.medicalgenomics.co.uk/ordering.php
Issue: Listed product name appears to be outdated ("Euro-DNA 1.0") -- I have emailed them for a clarification, at info@medicalgenomics.co.uk
-----end of list-----
The above list is accurate to the best of my knowledge. I encourage everyone to do their own investigations of all facts. Don't just take my word for anything; find out for yourself.
According to the information provided by the distributors, AncestryByDNA is available in the following parts of the world:
Australia
Canada
Caribbean (Jamaica, Tobago, Antigua, St.Lucia, Belize, Trinidad, Dominica, and Barbados)
European Union
France
Ireland
Italy
New Zealand
United Arab Emirates
United Kingdom
United States of America
Also, DNA Ancestors says it has "has experienced tremendous growth and expanded in to over 35 countries across the globe," and DNA Testing Solutions says, "We also serve international clients in over 168 countries."
I'm excited to see that AncestryByDNA has already become so global.
Daniel
Hi Jever,
No, I haven't sold a single share. I don't plan to, any time soon.
Daniel
Actually, "Porgie Tirebiter," that statement is incorrect. The list, and the linked document, clearly shows that EURO-DNA™ 2.0 was introduced on June 18, 2007 -- less than 2 years ago.
> C'mon Dan, the newest news on that "pipeline" page is four years old.
> http://www.dnaprint.com/welcome/pipeline/
Daniel
You're welcome!
Goldenstone,
I've spoken with Sarah a few times, and she's been polite and professional. I didn't ask for any information that might constitute material nonpublic information, because I don't want to step on that land mine. (Otherwise, I would have asked her all kinds of questions.) When I inquired about taking the AncestryByDNA test for myself (something I've intended to do, for a long time,) she did say there was a lab instrument that was down, but that it should be fixed in a "few weeks." (That was a week or so ago.) I'll try to get back in touch with her relatively soon, about that.
I'll also see if I can get a sense of just how many of the numerous AncestryByDNA distributors/providers, may actually be running DNAPrint Genomics' tests on their own equipment, and (one would presume) paying licensing fees to DNAPrint. If any such activity is occurring, that would be a previously unknown/unproven (to us) income stream, which would (in my opinion) have important implications, re: DNAG's value and the company's survivability during this financing squeeze.
Daniel
When you call, I suggest pressing 0. The last two times I called, Sarah answered the phone. I called just now, and I got her voicemail, though. Maybe she's out, busy, or (likely due to the time zone,) maybe she's at lunch. I'm not sure what her schedule looks like.
Daniel